F527
/ Lunan Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 23, 2022
Study of F527 in Patients With Relapsed or Refractory Lymphoma
(clinicaltrials.gov)
- P1 | N=82 | Not yet recruiting | Sponsor: Shandong New Time Pharmaceutical Co., LTD
New P1 trial • Hematological Malignancies • Lymphoma • Oncology
1 to 1
Of
1
Go to page
1